Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.

Prior to the DoE and execution, the scientist should clearly define how much variability in particle size distribution is considered practically significant, in that the variability over this predetermined range would likely have an impact on drug product quality.

also in 1,558 other papers